A Prandin, GlucoNorm, NovoNorm, Repaglinide written confirmation (Prandin, GlucoNorm, NovoNorm, Repaglinide WC) is an official document issued by a regulatory agency to a Prandin, GlucoNorm, NovoNorm, Repaglinide manufacturer, verifying that the manufacturing facility of a Prandin, GlucoNorm, NovoNorm, Repaglinide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Prandin, GlucoNorm, NovoNorm, Repaglinide APIs or Prandin, GlucoNorm, NovoNorm, Repaglinide finished pharmaceutical products to another nation, regulatory agencies frequently require a Prandin, GlucoNorm, NovoNorm, Repaglinide WC (written confirmation) as part of the regulatory process.
click here to find a list of Prandin, GlucoNorm, NovoNorm, Repaglinide suppliers with Written Confirmation (WC) on PharmaCompass.